Greenwich LifeSciences, Inc. (GLSI) stock
GLSINasdaqPharmaceutical PreparationsFiscal year ends December 31
$14.94−0.34 (-2.23%)
Close on Nov 13, 2026Market cap $219.29MP/E –Yield –
Greenwich LifeSciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Greenwich LifeSciences's enterprise value was $227.30M on Nov 11, 2026, against $116.62M a year earlier. Over the last 5 years it ranged from $80.50M to $411.00M, with a median of $163.59M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $227.30M | -20.5% |
| 2025 | Dec 31, 2025 | $286.02M | +101.7% |
| 2024 | Dec 31, 2024 | $141.79M | +12.5% |
| 2023 | Dec 29, 2023 | $126.02M | -29.9% |
| 2022 | Dec 30, 2022 | $179.65M | -37.5% |
| 2021 | Dec 31, 2021 | $287.23M | -33.3% |
| 2020 | Dec 31, 2020 | $430.34M | – |
See a number that looks wrong?